{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:28:01Z","timestamp":1715322481851},"reference-count":10,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.schres.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T19:01:05Z","timestamp":1393095665000},"page":"124-125","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment by asenapine for 5weeks decreases weight and triglycerides levels of Wistar rats"],"prefix":"10.1016","volume":"154","author":[{"given":"Rodrigo Bernini","family":"de Brito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo C\u00e9sar","family":"Ghedini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2014.02.002_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0053459","article-title":"Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine","volume":"8","author":"Boyda","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.schres.2014.02.002_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/JCP.0b013e31823f880a","article-title":"Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia","volume":"32","author":"Buchanan","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2014.02.002_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1359786813482533","article-title":"Management of schizophrenia: clinical experience with asenapine","volume":"27","author":"Cortese","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.schres.2014.02.002_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/11634500-000000000-00000","article-title":"Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder","volume":"26","author":"De Hert","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2014.02.002_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/JCP.0b013e3181d35d6b","article-title":"Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia","volume":"30","author":"Kane","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9896","key":"10.1016\/j.schres.2014.02.002_bb0030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2014.02.002_bb0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-006-0433-0","article-title":"A model for antipsychotic-induced obesity in the male rat","volume":"187","author":"Minet-Ringuet","year":"2006","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2014.02.002_bb0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0030-1248313","article-title":"Long-term assessment of asenapine vs. olanzapine in patients with schizophrenia or schizoaffective disorder","volume":"43","author":"Schoemaker","year":"2010","journal-title":"Pharmacopsychiatry"},{"issue":"8","key":"10.1016\/j.schres.2014.02.002_bb0045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","article-title":"Metabolic side effects of antipsychotic medication","volume":"61","author":"Tschoner","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.schres.2014.02.002_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S1516-44462012000200009","article-title":"Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine","volume":"34","author":"Zugno","year":"2012","journal-title":"Rev. Bras. Psiquiatr."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641400067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641400067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T11:58:43Z","timestamp":1538827123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641400067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":10,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S092099641400067X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2014.02.002","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment by asenapine for 5weeks decreases weight and triglycerides levels of Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2014.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}